Literature DB >> 35696262

Simultaneous Multiplexed Imaging of Biomolecules in Transgenic Mouse Brain Tissues Using Mass Spectrometry Imaging: A Multi-omic Approach.

Minh-Uyen Thi Le1,2, Hyun Kyong Shon1, Hong-Phuong Nguyen3, Chul-Ho Lee4, Kyoung-Shim Kim4, Hee-Kyung Na1, Tae Geol Lee1,2.   

Abstract

The importance of multi-omic-based approaches to better understand diverse pathological mechanisms including neurodegenerative diseases has emerged. Spatial information can be of great help in understanding how biomolecules interact pathologically and in elucidating target biomarkers for developing therapeutics. While various analytical methods have been attempted for imaging-based biomolecule analysis, a multi-omic approach to imaging remains challenging due to the different characteristics of biomolecules. Time-of-flight secondary ion mass spectrometry (ToF-SIMS) is a powerful tool due to its sensitivity, chemical specificity, and high spatial resolution in visualizing chemical information in cells and tissues. In this paper, we suggest a new strategy to simultaneously obtain the spatial information of various kinds of biomolecules that includes both labeled and label-free approaches using ToF-SIMS. The enzyme-assisted labeling strategy for the targets of interest enables the sensitive and specific imaging of large molecules such as peptides, proteins, and mRNA, a task that has been, to date, difficult for any MS analysis. Together with the strength of the analytical performance of ToF-SIMS in the label-free tissue imaging of small biomolecules, the proposed strategy allows one to simultaneously obtain integrated information of spatial distribution of metabolites, lipids, peptides, proteins, and mRNA at a high resolution in a single measurement. As part of the suggested strategy, we present a sample preparation method suitable for MS imaging. Because a comprehensive method to examine the spatial distribution of multiple biomolecules in tissues has remained elusive, our strategy can be a useful tool to support the understanding of the interactions of biomolecules in tissues as well as pathological mechanisms.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35696262      PMCID: PMC9261934          DOI: 10.1021/acs.analchem.2c00676

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   8.008


  36 in total

1.  TMT Labeling for the Masses: A Robust and Cost-efficient, In-solution Labeling Approach.

Authors:  Jana Zecha; Shankha Satpathy; Tamara Kanashova; Shayan C Avanessian; M Harry Kane; Karl R Clauser; Philipp Mertins; Steven A Carr; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2019-04-09       Impact factor: 5.911

Review 2.  Identification of biomarkers to diagnose diseases and find adverse drug reactions by metabolomics.

Authors:  Daisuke Saigusa; Naomi Matsukawa; Eiji Hishinuma; Seizo Koshiba
Journal:  Drug Metab Pharmacokinet       Date:  2020-12-24       Impact factor: 3.614

Review 3.  Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer.

Authors:  Matthias Holzlechner; Eliseo Eugenin; Brendan Prideaux
Journal:  Cancer Rep (Hoboken)       Date:  2019-12

Review 4.  Mass spectrometry imaging of therapeutics from animal models to three-dimensional cell cultures.

Authors:  Xin Liu; Amanda B Hummon
Journal:  Anal Chem       Date:  2015-07-02       Impact factor: 6.986

5.  Targeted multiplex imaging mass spectrometry in transmission geometry for subcellular spatial resolution.

Authors:  Gwendoline Thiery-Lavenant; Andre I Zavalin; Richard M Caprioli
Journal:  J Am Soc Mass Spectrom       Date:  2013-02-09       Impact factor: 3.109

6.  Imaging of amyloid-β in Alzheimer's disease transgenic mouse brains with ToF-SIMS using immunoliposomes.

Authors:  Louise Carlred; Vladana Vukojević; Björn Johansson; Martin Schalling; Fredrik Höök; Peter Sjövall
Journal:  Biointerphases       Date:  2016-06-22       Impact factor: 2.456

7.  Lanthanide polymer labels for multiplexed determination of biomarkers in human serum samples by means of size exclusion chromatography-inductively coupled plasma mass spectrometry.

Authors:  Emma Pérez; Katarzyna Bierla; Guillermo Grindlay; Joanna Szpunar; Juan Mora; Ryszard Lobinski
Journal:  Anal Chim Acta       Date:  2018-03-05       Impact factor: 6.558

8.  Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients.

Authors:  Adina N Lazar; Claudia Bich; Maï Panchal; Nicolas Desbenoit; Vanessa W Petit; David Touboul; Luce Dauphinot; Catherine Marquer; Olivier Laprévote; Alain Brunelle; Charles Duyckaerts
Journal:  Acta Neuropathol       Date:  2012-09-07       Impact factor: 17.088

9.  Integration of Alzheimer's disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.

Authors:  Edoardo Marcora; Alison M Goate; Gloriia Novikova; Manav Kapoor; Julia Tcw; Edsel M Abud; Anastasia G Efthymiou; Steven X Chen; Haoxiang Cheng; John F Fullard; Jaroslav Bendl; Yiyuan Liu; Panos Roussos; Johan Lm Björkegren; Yunlong Liu; Wayne W Poon; Ke Hao
Journal:  Nat Commun       Date:  2021-03-12       Impact factor: 14.919

Review 10.  Alzheimer's Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts.

Authors:  Camila Fabiani; Silvia S Antollini
Journal:  Front Cell Neurosci       Date:  2019-07-18       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.